Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Antiinfective Applications of Toll-like Receptor 9 Agonists

1 Jul 2007

Abstract excerpt

The innate immune system detects pathogens by the presence of highly conserved pathogen-expressed molecules, which trigger host immune defenses. Toll-like receptor (TLR) 9 detects unmethylated CpG dinucleotides in bacterial or viral DNA, and can be stimulated for therapeutic applications with synthetic oligodeoxynucleotides containing immune stimulatory "CpG motifs." TLR9 activation induces both innate and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Immune Response and Inflammation
Share to Pneumonia and Respiratory Infections
Share to Veterinary medicine and infectious diseases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 17607015
DOI: 10.1513/pats.200701-021aw

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Antiinfective Applications of Toll-like Receptor 9 AgonistsPMID 17607015Read ↗

A Review of the Role of CpG Oligodeoxynucleotides as Toll-Like Receptor 9 Agonists in Prophylactic and Therapeutic Vaccine Development in Infectious DiseasesSemantic proximity Read ↗

TLR9 in health and disease.Semantic proximity Read ↗

CpG Oligodeoxynucleotides as TLR9 AgonistsSemantic proximity Read ↗

Role of TLR9 in Oncogenic Virus-Produced CancerSemantic proximity Read ↗

CPG Oligonucleotides as Vaccine Adjuvants for Prevention of Infectious DiseasesSemantic proximity Read ↗

Recognition of CpG oligodeoxynucleotides by human Toll-like receptor 9 and subsequent cytokine induction.Semantic proximity Read ↗

Toll-Like Receptor 9 Activation with CpG Oligodeoxynucleotides for Asthma Therapy*Semantic proximity Read ↗

Immune interventions of human diseases through toll-like receptors.Semantic proximity Read ↗

Innate Immune RecognitionSemantic proximity Read ↗

Distinct Responses of Lung and Spleen Dendritic Cells to the TLR9 Agonist CpG OligodeoxynucleotideSemantic proximity Read ↗

‘Toll’ Gates for Future ImmunotherapySemantic proximity Read ↗

TLR, NLR Agonists, and Other Immune Modulators as Infectious Disease Vaccine AdjuvantsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.